The CCTU is part of the NIHR UKCRC Registered CTU Network and a member of the NCRI Cancer CTU Group.

The CCTU was established in 2011 and is hosted at the Cambridge University Hospitals NHS Foundation Trust (CUH) as part of the Cambridge Biomedical Research Centre.

The CCTU is part of the NIHR UKCRC Registered CTU Network and receives National Institute for Health Research CTU Support Funding. This funding has been awarded to support the unit in developing and supporting NIHR trials. CCTU is also a member of the NCRI Cancer CTU.

Our aim is to work in partnership with researchers to deliver the highest quality clinical trials and clinical research. The unit’s study portfolio covers a broad range of disease areas, mirroring the vast spectrum of research interest within Cambridge University Health Partners. These include, but are not limited to:

  • Oncology
  • Cardiovascular Disease
  • Infection and Immunity
  • Paediatrics
  • Neurology, Neurosciences, Trauma
  • Imaging
  • Surgery and Peri-operative Care
  • Public Health and Primary Care

The Unit is run by Professor Ian Wilkinson (Director) and Louise Stockley (Operations Director) and consists of:


A team of statisticians is involved in study design, sample size calculations, trials methodology, statistical analysis, and reporting.

Data Management

This team supports all aspects of data management activities: case report forms, data collection, data management plan, database development.

Trial Co-ordination and Trial Management

Study-specific coordinators work with investigators, statisticians and data managers on developing trial protocols, completion of submissions to REC, R&D departments and MHRA. They also support the set-up, conduct and close-down of clinical research studies. The team is involved in all types of clinical research study or trial.

Regulatory Affairs, Quality Assurance and Monitoring

This team supports clinical trials looking into the safety and efficacy of drugs (CTIMPs) to ensure GCP and regulatory requirements are met. The team provides guidance and advice on all trial aspects, including identification of trial associated costs, regulatory requirements and submissions, protocol development, pharmacovigilance, IMP management, initiation, monitoring of trial conduct, reporting obligations, close down and archiving.

Show on hub page: